CHAPTER X - PATHOLOGY / LABORATORY SERVICES

3y ago
17 Views
2 Downloads
288.76 KB
29 Pages
Last View : 18d ago
Last Download : 3m ago
Upload by : Albert Barnett
Transcription

CHAP10-CPTcodes80000-89999Revision Date: 1/1/2021CHAPTER XPATHOLOGY / LABORATORY SERVICESCPT CODES 80000 - 89999FORNATIONAL CORRECT CODING INITIATIVE POLICY MANUALFOR MEDICARE SERVICESCurrent Procedural Terminology (CPT) codes, descriptions andother data only are copyright 2020 American Medical Association.All rights reserved.CPT is a registered trademark of the American MedicalAssociation.Applicable FARS\DFARS Restrictions Apply to Government Use.Fee schedules, relative value units, conversion factors,prospective payment systems, and/or related components are notassigned by the AMA, are not part of CPT, and the AMA is notrecommending their use. The AMA does not directly or indirectlypractice medicine or dispense medical services. The AMA assumesno liability for the data contained or not contained herein.Revision Date (Medicare): 1/1/2021X-1

Table of ContentsChapter X . X-3Pathology and Laboratory Services CPT Codes 80000 - 89999 . X-3A.Introduction .X-3C.Organ or Disease Oriented Panels .X-7B.D.E.F.G.H.I.J.K.Evaluation & Management (E&M) Services .X-5Evocative/Suppression Testing .X-7Drug Testing .X-8Molecular Pathology .X-8Chemistry .X-10Hematology and Coagulation .X-11Immunology .X-13Transfusion Medicine .X-13Microbiology .X-14L. Anatomic Pathology (Cytopathology and Surgical Pathology).X-16M.N.Medically Unlikely Edits (MUEs) .X-20General Policy Statements .X-27Revision Date (Medicare): 1/1/2021X-2

Chapter XPathology and Laboratory ServicesCPT Codes 80000 - 89999A.IntroductionThe principles of correct coding discussed in Chapter I apply tothe Current Procedural Terminology (CPT) codes in the range80000-89999. Several general guidelines are repeated in thisChapter. However, those general guidelines from Chapter I notdiscussed in this chapter are nonetheless applicable.Physicians shall report the HCPCS/CPT code that describes theprocedure performed to the greatest specificity possible. AHealthcare Common Procedure Coding System/Current ProceduralTerminology (HCPCS/CPT) code shall be reported only if allservices described by the code are performed. A physician shallnot report multiple HCPCS/CPT codes if a single HCPCS/CPT codeexists that describes the services. This type of unbundling isincorrect coding.HCPCS/CPT codes include all services usually performed as partof the procedure as a standard of medical/surgical practice. Aphysician shall not separately report these services simplybecause HCPCS/CPT codes exist for them.The Centers for Medicare & Medicaid Services (CMS) oftenpublishes coding instructions in its rules, manuals, andnotices. Physicians must use these instructions when reportingservices rendered to Medicare patients.The "CPT Manual" also includes coding instructions which may befound in the “Introduction”, individual chapters, andappendices. In individual chapters, the instructions may appearat the beginning of a chapter, at the beginning of a subsectionof the chapter, or after specific CPT codes. Physicians shouldfollow "CPT Manual" instructions unless the CMS has provideddifferent coding or reporting instructions.Specific issues unique to this section of CPT are clarified inthis chapter.Pathology and laboratory CPT codes describe services to evaluatespecimens (e.g., blood, body fluid, tissue) obtained frompatients in order to provide information to the treatingphysician.Revision Date (Medicare): 1/1/2021X-3

Generally, pathology and laboratory specimens are prepared,screened, and/or tested by laboratory personnel with apathologist assuming responsibility for the integrity of theresults generated by the laboratory. Certain types of specimensand tests are reviewed or interpreted personally by thepathologist. CPT coding for this section includes few codesrequiring patient contact or Evaluation & Management (E&M)services rendered directly by the pathologist. If a pathologistprovides significant, separately identifiable face-to-facepatient care services that satisfy the criteria set forth in theE&M guidelines developed by the CMS and the AMA, a pathologistmay report the appropriate code from the E&M section of the "CPTManual."CMS policy prohibits separate payment for duplicate testing ortesting for the same analyte by more than one methodology. (Seedefinition of analyte in Section M (General Policy Statements),subsection 2.) If, after a test is ordered and performed,additional related procedures are necessary to provide or verifythe result, these would be considered part of the ordered test.For example, if a patient with leukemia has a thrombocytopenia,and a manual platelet count (CPT code 85032) is performed inaddition to the performance of an automated hemogram withautomated platelet count (CPT code 85027), it would beinappropriate to report CPT codes 85032 and 85027 because theformer provides verification for the automated hemogram andplatelet count (CPT code 85027). As another example, if apatient has an abnormal test result and repeat performance ofthe test is done to verify the result, the test is reported asone unit of service rather than 2.By contrast, some laboratory tests (if positive) requireadditional separate follow-up testing which is implicit in thephysician’s order. For example, if an RBC antibody screen (CPTcode 86850) is positive, the laboratory routinely proceeds toidentify the RBC antibody. The latter testing is separatelyreportable. Similarly, if a urine culture is positive, thelaboratory proceeds to organism identification testing which isseparately reportable. In these cases, the initial positiveresults have limited clinical value without the additionaltesting. The additional testing is separately reportablebecause it is not performed to complete the ordered test.Furthermore, the ordered test (if positive) requires theadditional testing in order to have clinical value. This typeof testing is a category of reflex testing that must bedistinguished from other reflex testing performed on a positivetest result which may have clinical value without additionalRevision Date (Medicare): 1/1/2021X-4

testing. An example of a latter type of test is a serum proteinelectrophoresis with a monoclonal protein band. A laboratoryshall not routinely perform serum immunofixation or serumimmunoelectrophoresis to identify the type of monoclonal proteinunless ordered by the treating physician. If the patient has aknown monoclonal gammopathy, perhaps identified at anotherlaboratory, the serum immunofixation or immunoelectrophoresiswould not be appropriate unless ordered by the treatingphysician.If a laboratory procedure produces multiple reportable testresults, only a single HCPCS/CPT code shall be reported for theprocedure. If there is no HCPCS/CPT code that describes theprocedure, the laboratory shall report a miscellaneous orunlisted procedure code with a single unit of service.B.Evaluation & Management (E&M) ServicesMedicare Global Surgery Rules define the rules for reporting E&Mservices with procedures covered by these rules. This sectionsummarizes some of the rules.All procedures on the Medicare Physician Fee Schedule areassigned a global period of 000, 010, 090, XXX, YYY, ZZZ, orMMM. The global concept does not apply to XXX procedures. Theglobal period for YYY procedures is defined by the MedicareAdministrative Contractor (MAC). All procedures with a globalperiod of ZZZ are related to another procedure, and theapplicable global period for the ZZZ code is determined by therelated procedure. Procedures with a global period of MMM arematernity procedures.Since National Correct Coding Initiative (NCCI) Procedure-toProcedure (PTP) edits are applied to same day services by thesame provider to the same beneficiary, certain Global SurgeryRules are applicable to the NCCI program. An E&M service isseparately reportable on the same date of service as a procedurewith a global period of 000, 010, or 090 days under limitedcircumstances.If a procedure has a global period of 090 days, it is defined asa major surgical procedure. If an E&M service is performed onthe same date of service as a major surgical procedure for thepurpose of deciding whether to perform this surgical procedure,the E&M service is separately reportable with modifier 57.Other preoperative E&M services on the same date of service as amajor surgical procedure are included in the global payment forRevision Date (Medicare): 1/1/2021X-5

the procedure and are not separately reportable. The NCCIprogram does not contain edits based on this rule because MACshave separate edits.If a procedure has a global period of 000 or 010 days, it isdefined as a minor surgical procedure. In general, E&M serviceson the same date of service as the minor surgical procedure areincluded in the payment for the procedure. The decision toperform a minor surgical procedure is included in the paymentfor the minor surgical procedure and shall not be reportedseparately as an E&M service. However, a significant andseparately identifiable E&M service unrelated to the decision toperform the minor surgical procedure is separately reportablewith modifier 25. The E&M service and minor surgical proceduredo not require different diagnoses. If a minor surgicalprocedure is performed on a new patient, the same rules forreporting E&M services apply. The fact that the patient is“new” to the provider is not sufficient alone to justifyreporting an E&M service on the same date of service as a minorsurgical procedure. The NCCI program contains many, but notall, possible edits based on these principles.For major and minor surgical procedures, postoperative E&Mservices related to recovery from the surgical procedure duringthe postoperative period are included in the global surgicalpackage as are E&M services related to complications of thesurgery. Postoperative visits unrelated to the diagnosis forwhich the surgical procedure was performed unless related to acomplication of surgery may be reported separately on the sameday as a surgical procedure with modifier 24 (“UnrelatedEvaluation and Management Service by the Same Physician or OtherQualified Health Care Professional During a PostoperativePeriod”).Procedures with a global surgery indicator of “XXX” are notcovered by these rules. Many of these “XXX” procedures areperformed by physicians and have inherent pre-procedure, intraprocedure, and post-procedure work usually performed each timethe procedure is completed. This work shall not be reported asa separate E&M code. Other “XXX” procedures are not usuallyperformed by a physician and have no physician work relativevalue units associated with them. A physician shall not reporta separate E&M code with these procedures for the supervision ofothers performing the procedure or for the interpretation of theprocedure. With most “XXX” procedures, the physician may,however, perform a significant and separately identifiable E&Mservice that is above and beyond the usual pre- and postRevision Date (Medicare): 1/1/2021X-6

operative work of the procedure on the same date of servicewhich may be reported by appending modifier 25 to the E&M code.This E&M service may be related to the same diagnosisnecessitating performance of the “XXX” procedure but cannotinclude any work inherent in the “XXX” procedure, supervision ofothers performing the “XXX” procedure, or time for interpretingthe result of the “XXX” procedure.C.Organ or Disease Oriented PanelsThe “CPT Manual” assigns CPT codes to organ- or disease-orientedpanels consisting of groups of specified tests. If all tests ofa CPT-defined panel are performed, the provider shall bill thepanel code. The panel codes shall be used when the tests areordered as that panel. For example, if the individually orderedtests are cholesterol (CPT code 82465), triglycerides (CPT code84478), and HDL cholesterol (CPT code 83718), the service shouldbe reported as a lipid panel (CPT code 80061) (See Chapter I,Section N (Laboratory Panel)).The NCCI program contains edits pairing each panel CPT code(Column One code) with each CPT code corresponding to theindividual laboratory tests that are included in the panel(Column Two code). These edits allow use of NCCI PTP-associatedmodifiers to bypass them if one or more of the individuallaboratory tests are repeated on the same date of service. Therepeat testing must be medically reasonable andnecessary. Modifiers 59 or 91 may be used to report this repeattesting. Based on the "Internet-only Manuals (IOM)," "MedicareClaims Processing Manual," Publication 100-04, Chapter 16,Section 100.5.1, the repeat testing cannot be performed to“confirm initial results; due to testing problems with specimensand equipment or for any other reason when a normal, one-time,reportable result is all that is required.”D.Evocative/Suppression TestingEvocative/suppression testing requires the administration ofpharmaceutical agents to determine a patient's response to thoseagents. CPT codes 80400-80439 describe the laboratorycomponents of the testing. Administration of the pharmaceuticalagent may be reported with CPT codes 96365-96376. In thefacility setting, these codes may be reported by the facility,but not the physician. In the non-facility setting, these codesmay be reported by the physician. While supplies necessary toperform the testing are included in the testing CPT codes, theappropriate HCPCS Level II J code for the pharmacologic agentRevision Date (Medicare): 1/1/2021X-7

may be reported separately. E&M services, including prolongedservices, should not be reported separately unless asignificant, separately identifiable service medicallyreasonable and necessary E&M is provided and documented.E.Drug Testing1.Beginning January 1, 2017, presumptive drug testing may bereported with CPT codes 80305-80307. These codes differ basedon the level of complexity of the testing methodology. Only onecode from this code range may be reported per date of service.Beginning January 1, 2016, definitive drug testing may bereported with HCPCS codes G0480-G0483. These codes differ basedon the number of drug classes including metabolites tested. OnJanuary 1, 2017, HCPCS code G0659 defining a different type ofdefinitive drug testing was added. Only one code from thisgroup of codes may be reported per date of service.For Calendar Year 2016, presumptive drug testing should havebeen reported with HCPCS codes G0477-G0479. These codesdiffered based on the level of complexity of the testingmethodology. Only one code from this code range should havebeen reported per date of service. (Codes 80300-80304 andG0477-G0479 were deleted January 1, 2017.)2.Providers performing validity testing on urinespecimens used for drug testing shall not separately bill thevalidity testing. For example, if a laboratory performs aurinary pH, specific gravity, creatinine, nitrates, oxidants, orother tests to confirm that a urine specimen is not adulterated,this testing is not separately billed.F.Molecular Pathology1.Physician (M.D. or D.O.) interpretation of a molecularpathology procedure (e.g., CPT codes 81161-81408) may bereported with HCPCS code G0452 when medically reasonable andnecessary. It shall not be reported with CPT code 88291(Cytogenetics and molecular cytogenetics, interpretation andreport).Several criteria must be satisfied in order to report HCPCS codeG0452. (See Section L (Medically Unlikely Edits (MUEs)),Subsection 4 for reporting requirements related to HCPCS codeG0452.) One criterion is that it requires the exercise ofmedical judgment. If the information could ordinarily beRevision Date (Medicare): 1/1/2021X-8

furnished by a nonphysician laboratory specialist, the servicedoes not require the exercise of medical judgment.2.Molecular pathology procedures (e.g., CPT codes 8116181408) include all aspects of sample preparation, cell lysis,internal measures to assure adequate quantity of DNA or RNA, andperformance of the assay. These procedures include DNA analysisand/or RNA analysis.3.Quantitation of extracted DNA and/or RNAin the payment for a molecular pathology procedurecodes 81161-81408). Other HCPCS/CPT codes such as84311 (Spectrophotometry.) shall not be reportedquantitation.is included(e.g., CPTCPT codefor this4.Scraping tumor off an unstained slide, if performed,is included in the payment for a molecular pathology procedure(e.g., CPT codes 81161-81408). A physician shall not reportmicrodissection (CPT codes 88380 or 88381) for this process.The microdissection CPT codes require a pathologist to use lasercapture microdissection (CPT code 88380) or a dissectingmicroscope (CPT code 88381) to distinguish malignant cells fromnonmalignant cells.5.CPT codes 81445, 81450, and 81455 describe targetedgenomic sequence analysis. 81445 applies to solid organneoplasm type (5-50 genes) and 81450 applies to hematolymphoidneoplasm type (5-50 genes), while 81455 applies to the number ofgenes analyzed for either a solid or hematolymphoid neoplasm (51or greater genes). Providers/suppliers may not report 81455with either 81445 or 81450.6.All genomic sequencing procedures and molecularmultianalyte assays (e.g., CPT codes 81410-81471), manymultianalyte assays with algorithmic analyses (e.g., CPT codes81493-81599, 0004M-XXXXM), and many Proprietary LaboratoryAnalyses (PLA) (e.g., CPT codes 0001U-XXXXU) are DNA or RNAanalytic methods that simultaneously assay multiple genes orgenetic regions. A physician shall not additionally separatelyreport testing for the same gene or genetic region by adifferent methodology (e.g., CPT codes 81105-81408, 81479,88364-88377). CMS payment policy does not allow separatepayment for multiple methods to test for the same analyte.7.A Tier 1 or Tier 2 molecular pathology procedure CPTcode should not, in general, be reported with a genomicsequencing procedure, molecular multianalyte assay, multianalyteRevision Date (Medicare): 1/1/2021X-9

assay with algorithmic analysis, or proprietary laboratoryanalysis CPT code where the CPT code descriptor includes testingfor the analyte described by the Tier 1 or Tier 2 molecularpathology code. Procedures reported together must be bothmedically reasonable and necessary (e.g., sequencing ofprocedures) and ordered by the physician who is treating thebeneficiary and using the results in the management of thebeneficiary's specific medical problem.8.If one laboratory procedure evaluates multiple genesusing a next generation sequencing procedure, the laboratoryshall report only one unit of service of one genomic sequencingprocedure, molecular multianalyte assay, multianalyte assay withalgorithmic analysis, or proprietary laboratory analysis CPTcode. If no CPT code accurately describes the procedureperformed, the laboratory may report CPT code 81479 (Unlistedmolecular pathology procedure) with one unit of service or mayreport multiple individual CPT codes describing the componenttest results when medically reasonable and necessary. Proceduresreported together must be both medically reasonable andnecessary (e.g., sequencing of procedures) and ordered by thephysician who is treating the beneficiary and using the resultsin the management of the beneficiary's specific medical problem.9.PTP edits bundling 2 Tier 1 molecular pathologyprocedure CPT codes describe procedures that should not, ingeneral, be reported together. For example, CPT code 81292describes full sequence gene analysis of MLH1, and CPT code81294 describes duplication/deletion variant gene analysis ofMLH1. In evaluating a patient with colon carcinoma

Generally, pathology and laboratory specimens are prepared, screened, and/or tested by laboratory personnel with a pathologist assuming responsibility for the integrity of the results generated by the laboratory. Certain types of specimens and tests are reviewed or interpreted personally by the pathologist.

Related Documents:

Vista Pathology Laboratory – User’s Guide 1 Who We Are Reedy, Michael MD Pathology Nixon, Randal MD, PhD Pathology Neuropathology Loudermilk, Allison MD Pathology Hematopathology Wu, Bryan MD Pathology Breast Pathology Dermatopathology Pike, Robin MD Pathology Cy

Part One: Heir of Ash Chapter 1 Chapter 2 Chapter 3 Chapter 4 Chapter 5 Chapter 6 Chapter 7 Chapter 8 Chapter 9 Chapter 10 Chapter 11 Chapter 12 Chapter 13 Chapter 14 Chapter 15 Chapter 16 Chapter 17 Chapter 18 Chapter 19 Chapter 20 Chapter 21 Chapter 22 Chapter 23 Chapter 24 Chapter 25 Chapter 26 Chapter 27 Chapter 28 Chapter 29 Chapter 30 .

Pathology: Molecular Pathology Page updated: August 2020 This section contains information to help providers bill for clinical laboratory tests or examinations related to molecular pathology and diagnostic services. Molecular Pathology Code Chart The chart included later in this section correlates molecular pathology CPT and HCPCS

TO KILL A MOCKINGBIRD. Contents Dedication Epigraph Part One Chapter 1 Chapter 2 Chapter 3 Chapter 4 Chapter 5 Chapter 6 Chapter 7 Chapter 8 Chapter 9 Chapter 10 Chapter 11 Part Two Chapter 12 Chapter 13 Chapter 14 Chapter 15 Chapter 16 Chapter 17 Chapter 18. Chapter 19 Chapter 20 Chapter 21 Chapter 22 Chapter 23 Chapter 24 Chapter 25 Chapter 26

DEDICATION PART ONE Chapter 1 Chapter 2 Chapter 3 Chapter 4 Chapter 5 Chapter 6 Chapter 7 Chapter 8 Chapter 9 Chapter 10 Chapter 11 PART TWO Chapter 12 Chapter 13 Chapter 14 Chapter 15 Chapter 16 Chapter 17 Chapter 18 Chapter 19 Chapter 20 Chapter 21 Chapter 22 Chapter 23 .

Anatomic Pathology (AP) and Clinical Pathology (CP, Laboratory Medicine) in order to prepare each of our residents for certification by the American Board of Pathology. A core program provides training that will lead to basic competence in general pathology. Elective opportunities are offered to permit the

Subspecialty: Hepatobiliary Pathology, Gastrointestinal Pathology Assistant Professor of Pathology Dr. Kiyoko Oshima is the Director of Clinical Hepatic Pathology and Assistant Professor in the Department of Pathology at the Johns Hopkins Hospital University School of Medicine. She joined the Hopkins faculty in 2017.

Chicago Pathology Society CLINICAL INTERESTS: Neuropathology, Cytopathology, Autopsy, Surgical Pathology pathology.osu.edu Saman SeyedAhmadian, MD is an Assistant Professor - Clinical for Ohio State’s Department of Pathology. Insert photo here THE OHIO STATE UNIVERSITY DEPARTMENT OF PATHOLOGY